AmyloiDia is a medtech company founded by researchers from Karolinska Institutet and Stockholm University that is built on our invention of a method that can detect with single-molecule sensitivity structured peptide/protein aggregates that are called amyloids, and uniquely measure their concentration and size. Amyloid formation is implicated in more than 40 diseases, collectively called amyloid diseases, but it is also a problem in the biotechnology and pharmaceutical industry. We focus on the translation of our methodology to healthcare, to enable early blood-based diagnosis of amyloid diseases such as Alzheimer’s disease.”

Visit site